Clinical Trial

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness

Study acronym: ASH-2
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to measure the effect of Diffusion Optics Technology (DOT) spectacle lenses on the choroidal thickness and choroidal vascularity index compared to control lenses.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-11-11; most recent amendment 2026-04-29.
Status change: Recruiting → Active, Not Recruiting 2023-12-05
Status change: Not Yet Recruiting → Recruiting 2023-04-10
Trial Details
NCT Number NCT05617794
Lead Sponsor SightGlass Vision, Inc.
Collaborators: University of Waterloo
Conditions Myopia, Myopia Progression, Juvenile Myopia
Enrollment 30 participants
Start Date 2023-01-18
Primary Completion 2023-04-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-05